Department of Ophthalmology, Shimane University Faculty of Medicine, 89-1 Enya, Izumo, Shimane, Japan.
Japan Medical Affairs Group, Santen Pharmaceutical Co., Ltd., 4-20 Ofukacho, Kita-ku, Osaka, Japan.
Adv Ther. 2023 Nov;40(11):4907-4918. doi: 10.1007/s12325-023-02646-3. Epub 2023 Sep 14.
To report eyedrop instillation techniques and factors associated with instillation failure among glaucoma subjects in the Video-Recorded Assessment of Medication Skill and Questionnaire-based evaluation of Perception in Glaucoma Study.
In this cross-sectional observational study, subjects were 60 patients with glaucoma (mean ± standard deviation age, 68.4 ± 11.3 years; 30 men) who required ocular hypotensive medication(s). Subjects completed ophthalmologic examinations and the Mini-Cog cognitive function test; their typical eyedrop instillation technique was video-recorded. Subjects rated their technique as successes/failures by questionnaire and two examiners rated the successes/failures based on video assessment. Discrepancy between self-reported and video-assessed success/failure rates of instillation was the main outcome measures. Multivariate logistic regression identified factors in instillation failure.
Of 48/56 (86%) self-reported successes, 27/48 (56%) failed based on video assessment; as a result, 32/56 (57%) were inconsistent between subjective and objective assessments. Overall, 30/56 (54%) failed based on video assessment. In the subject-based data model, older age [odds ratio (OR) 0.93/year, P = 0.025] and lower cognitive function score (OR 2.7/score, P = 0.025) were factors in failed instillations. In the eye-based data model, less myopic objective refractive error (OR 0.77/diopter, P = 0.016) and lower visual field foveal threshold (OR 1.1/decibel, P = 0.041) were factors in failures.
In addition to older age, decreased cognitive function, hyperopia, and decreased foveal sensitivity are risks for failed eyedrop instillation. Treating physicians can screen patients who require guidance by checking the risk factors of instillation failure rather than by relying on patient reports.
报告了在“录像评估药物技能和基于问卷的青光眼感知评估”研究中,青光眼患者滴眼技术和滴眼失败相关因素。
在这项横断面观察性研究中,受试者为 60 名需要眼部降压药物治疗的青光眼患者(平均年龄±标准差为 68.4±11.3 岁,男性 30 名)。受试者完成眼科检查和 Mini-Cog 认知功能测试;他们的典型滴眼技术被录像记录。受试者通过问卷和两名检查者根据视频评估来评估自己的技术成功率/失败率。自我报告和视频评估的滴眼成功率/失败率之间的差异是主要的观察指标。多变量逻辑回归确定了滴眼失败的因素。
在 48/56(86%)自我报告的成功中,27/48(56%)基于视频评估失败;因此,32/56(57%)在主观和客观评估之间不一致。总体而言,30/56(54%)基于视频评估失败。在基于受试者的数据分析模型中,年龄较大(每增加 1 岁的优势比[OR]为 0.93,P=0.025)和认知功能评分较低(OR 2.7/分,P=0.025)是滴眼失败的因素。在基于眼睛的数据分析模型中,较低的客观近视屈光误差(OR 0.77/屈光度,P=0.016)和较低的视野中心凹阈值(OR 1.1/分贝,P=0.041)是滴眼失败的因素。
除了年龄较大外,认知功能下降、远视和中心凹敏感性下降也是滴眼失败的危险因素。治疗医生可以通过检查滴眼失败的危险因素来筛选需要指导的患者,而不是依赖患者的报告。